CEO, Robert L. Cucin is interviewed by Michael Yorba on the I Heart Radio’s “Traders Network Show” on April 11, 2015.
Dr. Cucin discusses the rationale and potential of the endoscopic visceral lipectomy methods and devices the company is developing for the treatment of obesity, metabolic syndrome and type 2 diabetes.
BioSculpture Technology’s patented technology now makes it possible to safely and efficiently remove visceral or “belly” fat inside the abdomen for the first time. This method has the potential of becoming a safer and highly effective alternative to current bariatric surgical treatments of obesity, metabolic syndrome and type 2 diabetes mellitus.
[youtube=http://youtu.be/ahK2YKypUTM]
BioSculpture Technology, Inc. initiates a campaign to kick start development of the treatment contemplated by two recently issued U.S. patents to endoscopically removal visceral fat.
Visceral fat is a noxious hormone factory secreting cytokines which make obese and overweight patients insulin resistant and develop type 2 diabetes mellitus, hypertension, slows their metabolism, and promotes coronary artery disease, inflammatory diseases and cancers. The literature and some early clinical studies have shown removing it has immediately beneficial effects in reversing those metabolic effects.
Please take the time to learn more about this and help us bring it to the 1.3 billion people whom it can benefit faster.
http://www.indiegogo.com/project/445739/widget/3646746